Amarin | AMRN - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
AbbVie USD 384.69B 19.14B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
AstraZeneca USD 197.73B 92.26B 2026-07
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
DBV Technologies USD 629M 601M 2026-07
GlaxoSmithKline GBP 84.53B 735.04M 2026-07
Halozyme Therapeutics USD 7.66B 257M 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 264.25B 23.66B 2026-07